Cargando…
Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing
Phenylketonuria (PKU) is a metabolic disorder whereby phenylalanine metabolism is deficient due to allelic variations in the gene for phenylalanine hydroxylase (PAH). There is no cure for PKU other than orthotopic liver transplantation, and the standard of care for patients is limited to dietary res...
Autores principales: | Kaiser, Robert A., Carlson, Daniel F., Allen, Kari L., Webster, Dennis A., VanLith, Caitlin J., Nicolas, Clara T., Hillin, Lori G., Yu, Yue, Kaiser, Catherine W., Wahoff, William R., Hickey, Raymond D., Watson, Adrienne L., Winn, Shelley R., Thöny, Beat, Kern, Douglas R., Harding, Cary O., Lillegard, Joseph B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833140/ https://www.ncbi.nlm.nih.gov/pubmed/33493163 http://dx.doi.org/10.1371/journal.pone.0245831 |
Ejemplares similares
-
Use of an adeno‐associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model
por: Kaiser, Robert A., et al.
Publicado: (2021) -
In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions
por: Nicolas, Clara T., et al.
Publicado: (2022) -
Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1
por: Hickey, Raymond D., et al.
Publicado: (2018) -
The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism
por: Thompson, Whitney S., et al.
Publicado: (2020) -
Ex Vivo Hepatocyte Reprograming Promotes Homology‐Directed DNA Repair to Correct Metabolic Disease in Mice After Transplantation
por: VanLith, Caitlin J., et al.
Publicado: (2019)